The results of this study indicated BMSCs-Exo silenced E2F2 in NSCLC via delivering miR-631 to NSCLC cells to repress the malignant behavior of NSCLC, which was verified in vivo experiments. Here, E2F2 is linked to non-small cell lung carcinoma.